381 studies found for:    Open Studies | Exclude Unknown | "heart disease"OR"stroke"OR"cardiovascular disease" | United States | Phase 1, 2, 3, 0 | Industry
Show Display Options
Rank Status Study
21 Recruiting SPYRAL HTN-ON MED Study
Conditions: Hypertension;   Vascular Diseases;   Cardiovascular Diseases
Interventions: Device: Symplicity Spyral™ multi-electrode renal denervation system;   Procedure: Sham Procedure
22 Recruiting SPYRAL HTN-OFF MED Study
Conditions: Hypertension;   Vascular Diseases;   Cardiovascular Diseases
Interventions: Device: Symplicity Spyral™ multi-electrode renal denervation system;   Procedure: Sham Procedure
23 Recruiting BIONICS - Pharmacokinetics (PK) Trial
Condition: Heart Disease
Intervention: Device: BioNIR Ridaforolimus Eluting Coronary Stent
24 Recruiting A Study of the Efficacy and Safety of Activase (Alteplase) in Patients With Mild Stroke (PRISMS)
Condition: Brain Ischemia
Interventions: Drug: alteplase [Activase];   Drug: alteplase placebo;   Drug: aspirin;   Drug: aspirin placebo
25 Recruiting Evaluation of Safety and Efficacy of Lumason in Pediatric Echocardiography
Condition: Congenital Heart Disease
Intervention: Drug: sulphur hexafluoride lipid-type A microspheres
26 Recruiting Safety and Efficacy Study of a Protease Activated Receptor-4 Antagonist Being Tested to Reduce the Chances of Having Additional Strokes or "Mini Strokes"
Condition: Thrombosis
Interventions: Drug: BMS-986141;   Drug: Aspirin;   Other: Placebo
27 Recruiting Active Preoperative Anemia Management in Patients Undergoing Cardiac Surgery
Conditions: Anemia;   Cardiovascular Disease
Interventions: Drug: EPO;   Drug: Feraheme
28 Recruiting Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy
Condition: Hypertrophic Cardiomyopathy
Interventions: Drug: Eleclazine;   Drug: Placebo
29 Recruiting A Pivotal Trial to Establish the Efficacy and Long-term Safety of the Parachute Implant System
Conditions: Congestive Heart Failure;   Left Ventricular (LV) Systolic Dysfunction
Intervention: Device: CardioKinetix Parachute Implant and All Appropriate Medical Therapy (AAMT)
30 Not yet recruiting Bococizumab HIV Evaluation (B-HIVE) Study
Conditions: Dyslipidemia;   Cardiovascular Disease
Interventions: Drug: Bococizumab;   Drug: Placebo
31 Recruiting The COPPER-A Trial
Conditions: Peripheral Arterial Disease;   Cardiovascular Disease;   Peripheral Vascular Disease
Intervention: Other: Paclitaxel administration using the OPC
32 Recruiting BOTOX® Open-Label Treatment in Pediatric Upper Limb Spasticity
Conditions: Pediatrics;   Muscle Spasticity;   Cerebral Palsy;   Stroke
Intervention: Biological: botulinum toxin Type A
33 Recruiting BOTOX® Treatment in Pediatric Upper Limb Spasticity
Conditions: Pediatrics;   Muscle Spasticity;   Cerebral Palsy;   Stroke
Interventions: Biological: botulinum toxin Type A;   Drug: Normal Saline (Placebo)
34 Recruiting Brachial Artery Ultrasound Imaging: A Repeatability Study
Condition: Cardiovascular Diseases
Intervention: Procedure: Brachial artery ultrasound imaging
35 Recruiting Safety of Autologous Human Umbilical Cord Blood Treatment for Perinatal Arterial Ischemic Stroke
Condition: Perinatal Arterial Ischemic Stroke
Intervention: Biological: Autologous Cord Blood Infusion
36 Recruiting Treadmill CV Safety Study
Condition: Stable Angina
Interventions: Drug: AMG 334;   Drug: Placebo
37 Recruiting Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
Condition: Atherosclerosis
Interventions: Drug: Canakinumab;   Drug: Placebo
38 Recruiting Targeted Electrotherapy for Aphasia Stroke Rehabilitation (TEASER) - Phase II Multi-Center Study
Condition: Chronic Aphasia
Interventions: Device: HD-tDCS (Soterix Medical, Active);   Device: HD-tDCS (Soterix Medical, Sham)
39 Recruiting Rivaroxaban for the Prevention of Major Cardiovascular Events in Coronary or Peripheral Artery Disease
Condition: Prevention &Amp; Control
Interventions: Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Aspirin;   Drug: Aspirin placebo;   Drug: Rivaroxaban placebo;   Drug: Pantoprazole
40 Recruiting Effects of Resveratrol Supplements on Vascular Health in Postmenopausal Women
Condition: Cardiovascular Disease
Interventions: Dietary Supplement: ResA;   Dietary Supplement: Resveratrol;   Dietary Supplement: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years